Anzeige
Mehr »
Samstag, 12.07.2025 - Börsentäglich über 12.000 News
Der nächste Volltreffer direkt neben einer brandneuen Entdeckung! Kupfer im Höhenflug!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41009 | ISIN: US92731L3042 | Ticker-Symbol:
NASDAQ
22.04.25 | 22:00
0,100 US-Dollar
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
VINCERX PHARMA INC Chart 1 Jahr
5-Tage-Chart
VINCERX PHARMA INC 5-Tage-Chart

Aktuelle News zur VINCERX PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoVincerx announces potential distribution of $0.04-$0.08 per share2
MoVincerx Pharma, Inc. - 8-K, Current Report2
MoVincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders71Potential Distribution Range of $0.04 to $0.08 per share of outstanding stock based on current estimates and assumptions, including timely approval of Distribution Proposal Failure to approve Dissolution...
► Artikel lesen
18.06.Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal8
17.04.NASDAQ wird Vincerx Pharma bis zum 23. April von der Börse nehmen10
VINCERX PHARMA Aktie jetzt für 0€ handeln
17.04.Nasdaq to delist Vincerx Pharma by April 231
17.04.Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC181Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025 Trading to be permanently suspended by Nasdaq at the open of business on April...
► Artikel lesen
11.04.Vincerx Pharma, Inc. - 8-K, Current Report1
09.04.Vincerx's final merger attempt collapses, leaving ADC biotech to wind down5
08.04.Vincerx Pharma ends merger talks, begins asset wind-down1
08.04.Vincerx Pharma beendet Fusionsgespräche und leitet Vermögensabwicklung ein3
08.04.Vincerx Pharma, Inc.: Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities132SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global...
► Artikel lesen
27.03.Vincerx Pharma, Inc. - 10-K, Annual Report3
18.03.Vincerx, left in limbo by collapsed deal, moves to merge with AI company to escape cash crisis2
18.03.Vincerx Pharma announces non-binding LOI for Qumulus AI combination3
18.03.Vincerx Pharma plant Reverse-Merger mit QumulusAI2
18.03.Vincerx Pharma plans reverse merger with QumulusAI2
18.03.Vincerx Pharma, Inc. - 8-K, Current Report-
18.03.Vincerx Pharma, Inc.: Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI489SAN MATEO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has entered into a non-binding letter of intent ("LOI") with Global Digital Holdings...
► Artikel lesen
28.02.Vincerx Pharma terminates reverse merger term sheet and evaluates strategic alternatives10
Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1